Lisa Lancaster
-
New drugs approved to fight idiopathic pulmonary fibrosis
The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF). Read MoreJan 15, 2015
-
Study examines sleep apnea’s role in lung diseases
Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases. Read MoreApr 13, 2012
-
Lung disorder drug regimen found harmful
Longtime treatment for IPF ineffective and even dangerous. Read MoreOct 31, 2011